| 商品名 | 申请号 | 产品号 | 申请类型 | 活性成分 | 剂型/给药途径 | 规格/剂量 | RLD | RS | 申请号原始批准/暂定批准日期 | 产品号批准日期 | 申请人 | 市场状态 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TOFACITINIB CITRATE | 212943 | 001 | ANDA | TOFACITINIB CITRATE | TABLET;ORAL | EQ 10MG BASE | No | No | 2021/06/01 | 2021/06/01 | AJANTA PHARMA LTD | Discontinued |
| TOFACITINIB CITRATE | 212943 | 001 | ANDA | TOFACITINIB CITRATE | TABLET;ORAL | EQ 10MG BASE | No | No | 2021/06/01 (TA) | 2021/06/01 | AJANTA PHARMA LTD | Discontinued |
| TOFACITINIB CITRATE | 209738 | 001 | ANDA | TOFACITINIB CITRATE | TABLET;ORAL | EQ 5MG BASE | No | No | 2023/03/13 | 2023/03/13 | MICRO LABS | Discontinued |
| TOFACITINIB CITRATE | 209738 | 001 | ANDA | TOFACITINIB CITRATE | TABLET;ORAL | EQ 5MG BASE | No | No | 2023/03/13 (TA) | 2023/03/13 | MICRO LABS | Discontinued |
| TOFACITINIB CITRATE | 209829 | 001 | ANDA | TOFACITINIB CITRATE | TABLET;ORAL | EQ 5MG BASE | No | No | 2023/03/14 | 2023/03/13 | ZYDUS PHARMS | Discontinued |
| TOFACITINIB CITRATE | 216878 | 001 | ANDA | TOFACITINIB CITRATE | SOLUTION;ORAL | EQ 1MG BASE/ML | No | No | 2023/09/25 | 2023/09/25 | SLAYBACK PHARMA LLC | Prescription |